J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer
"New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial
New Drug For IDH1 Mutation/Relapsed/Refractory Acute Myeloid Leukaemia With Good Complete Remission Rates And Manageable Toxicity
Watch Out For The Me Better 'Trap' Behind The Changing Future Of Frα Adc Rising Stars
Four Measures To Combat Bronchitis
Airway Announces First Patient To Receive Dose In Bpd Trial
